Triple

T19773095
Position Surface form Disambiguated ID Type / Status
Subject Xeljanz E474935 entity
Predicate belongsToTherapeuticClass P24600 FINISHED
Object disease-modifying antirheumatic drugs LITERAL FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: disease-modifying antirheumatic drugs | Statement: [Xeljanz, belongsToTherapeuticClass, disease-modifying antirheumatic drugs]
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: belongsToTherapeuticClass
Context triple: [Xeljanz, belongsToTherapeuticClass, disease-modifying antirheumatic drugs]
  • A. hasPharmacologicClass chosen
    Indicates that a drug or medicinal product belongs to a specific pharmacologic class based on its mechanism of action or therapeutic effect.
  • B. isClassifiedUnder
    Indicates that one entity is categorized or grouped within a broader class, type, or category represented by another entity.
  • C. protectedDrugClassesInclude
    Indicates that the specified set of protected drug classes includes the referenced drug class or classes.
  • D. hasTherapeuticGoal
    Indicates that an action, treatment, or intervention is undertaken with the intention of achieving a specific therapeutic or health-related outcome.
  • E. drugClass
    Indicates that one entity is classified as a particular pharmacological or therapeutic category of drugs in relation to another entity.
  • F. None of above.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8e51a43a08190956bc6df13c91a77 completed April 10, 2026, 11:55 a.m.
NER Named-entity recognition batch_69e6535e450c8190a2628245ae0d0bd3 completed April 20, 2026, 4:25 p.m.
PD Predicate disambiguation batch_69e53053ed2881908400becdfada7fd3 completed April 19, 2026, 7:43 p.m.
Created at: April 10, 2026, 1:48 p.m.